Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  AstraZeneca PLC    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

ASTRAZENECA : JP Morgan reiterates its Buy rating

share with twitter share with LinkedIn share with facebook
06/25/2020 | 03:42am EDT

Analyst James Gordon from JP Morgan research considers the stock attractive and recommends it with a Buy rating. The target price continues to be set at GBX 9500.


© MarketScreener with dpa-AFX Analyser 2020
share with twitter share with LinkedIn share with facebook
Latest news on ASTRAZENECA PLC
08/11U.S. inks $1.5 billion deal with Moderna for 100 million doses of COVID-19 va..
RE
08/11J&J eyes 1 billion doses of potential COVID-19 shot in 2021, weighs challenge..
RE
08/11ASTRAZENECA : Partners with Actor and Author Tony Hale to Build Awareness of Eos..
BU
08/11Sinovac launches Phase 3 trial for COVID-19 vaccine in Indonesia, reports Pha..
RE
08/10Inovio to begin mid-to-late stage study of COVID-19 vaccine candidate in Sept..
RE
08/10Inovio to begin mid-to-late stage study of COVID-19 vaccine candidate in Sept..
RE
08/10DAIICHI SANKYO : Announces Clinical Trial Collaboration with AstraZeneca to Eval..
AQ
08/07Brazilian billionaire Lemann leads initiative to build COVID-19 vaccine facto..
RE
08/07London stocks gain on week; U.S. jobs data, tensions with China weigh
RE
08/07GLOBAL MARKETS LIVE: Uber, Booking, and other earnings reports today
More news
Financials (USD)
Sales 2020 26 712 M - -
Net income 2020 3 067 M - -
Net Debt 2020 13 578 M - -
P/E ratio 2020 50,6x
Yield 2020 2,55%
Capitalization 145 B 145 B -
EV / Sales 2020 5,93x
EV / Sales 2021 5,20x
Nbr of Employees 70 600
Free-Float 95,7%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 113,90 $
Last Close Price 110,26 $
Spread / Highest target 32,0%
Spread / Average Target 3,29%
Spread / Lowest Target -45,6%
EPS Revisions
Managers
NameTitle
Pascal Soriot Chief Executive Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Pam P. Cheng Executive VP-Operations & Information Technology
Marc Pierre Jean Dunoyer Chief Financial Officer & Executive Director
Menelas N. Pangalos EVP-Biopharmaceuticals Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
ASTRAZENECA PLC11.08%145 048
JOHNSON & JOHNSON1.48%386 946
ROCHE HOLDING AG-0.35%292 091
PFIZER, INC.-3.55%209 994
MERCK & CO., INC.-11.04%204 641
NOVARTIS AG-17.07%183 277